• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4608647)   Today's Articles (4666)   Subscriber (49376)
For: Saad F. Androgen deprivation in prostate cancer: first do no harm. Lancet Oncol 2017;18:1142-1144. [DOI: 10.1016/s1470-2045(17)30573-9] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/31/2017] [Revised: 06/28/2017] [Accepted: 06/28/2017] [Indexed: 10/19/2022]
Number Cited by Other Article(s)
1
Saad F. Quality of life in men with prostate cancer. Lancet Oncol 2019;20:325-326. [PMID: 30713037 DOI: 10.1016/s1470-2045(18)30863-5] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/05/2018] [Accepted: 11/06/2018] [Indexed: 10/27/2022]
2
Duchesne GM, Woo HH. Timing of androgen-deprivation therapy in prostate cancer – Author's reply. Lancet Oncol 2017;18:e635. [DOI: 10.1016/s1470-2045(17)30799-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/04/2017] [Accepted: 10/09/2017] [Indexed: 11/25/2022]
3
Nandagopal L. Timing of androgen-deprivation therapy in prostate cancer. Lancet Oncol 2017;18:e634. [DOI: 10.1016/s1470-2045(17)30775-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/24/2017] [Accepted: 09/29/2017] [Indexed: 10/18/2022]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA